Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/11/25 17:37 | 4/29/25 | ACLX | Health | BioPrd | Biological Products, (No Diag | Patel Kavita | CA | D | 8 | M.d | 411 | 34.27 | 0 | 12 | 0 | D | ||||||||||||||||
6/11/25 17:37 | 4/29/25 | ACLX | Health | BioPrd | Biological Products, (No Diag | Patel Kavita | CA | D | 8 | S.d | -411 | 34.27 | 0 | -12 | -100 | 0 | D | |||||||||||||||
5/28/25 20:18 | 5/23/25 | ACLX | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | CA | O | CFO | 2 | M.d | 785 | 22.64 | 0 | 35 | 20 | D | |||||||||||||||
5/28/25 20:18 | 5/27/25 | ACLX | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | CA | O | CFO | 2 | S.d | -785 | 22.64 | 0 | -35 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |